No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
rituximab
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
rituximab
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
vemurafenib + rituximab
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
pentostatin
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
rituximab/hyaluronidase
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
rituximab
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
vemurafenib
Sensitive: A2 - Guideline
|
No biomarker
No biomarker
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
ibrutinib
Sensitive: A2 - Guideline
|
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
dabrafenib
Sensitive: C2 – Inclusion Criteria
|
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
vemurafenib
Sensitive: C2 – Inclusion Criteria
|
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
vemurafenib
Sensitive: C2 – Inclusion Criteria
|
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
dabrafenib + rituximab
Sensitive: C3 – Early Trials
|
MYD88 L265P + BRAF V600E
MYD88 L265P + BRAF V600E
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
rituximab
Sensitive: C4 – Case Studies
|
KRAS mutation
KRAS mutation
|
Hairy Cell Leukemia
Hairy Cell Leukemia
|
vemurafenib
Resistant: C4 – Case Studies
|
